Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
SMX - SMX (Security Matters) Plc - Stock Price Chart
TickerSMX [NASD]
CompanySMX (Security Matters) Plc
CountryIreland
IndustrySpecialty Business Services
Market Cap0.67MEPS (ttm)-2868.77
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.06EPS Q/Q-64761.11%
Dividend-Sales Q/Q-
Insider Own52.99%Inst Own9.57%
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume131.92K52W Range4.33 - 285.00
SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.
ARL - American Realty Investors Inc. - Stock Price Chart
TickerARL [NYSE, RUT]
CompanyAmerican Realty Investors Inc.
CountryUSA
IndustryReal Estate Services
Market Cap313.63MEPS (ttm)0.17
P/E114.44EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-53.09%
P/S6.18EPS next 5Y-
P/B0.51EPS Q/Q-41.21%
Dividend-Sales Q/Q1.81%
Insider Own90.99%Inst Own3.39%
Insider Trans0.00%Inst Trans-1.52%
Short Float1.81%Earnings-
Analyst Recom-Target Price-
Avg Volume7.86K52W Range11.69 - 25.96
American Realty Investors, Inc. engages in the acquisition, financing, operation, and sale of real estate and real estate assets. Its projects include office buildings, golf course, and residential apartments. The company was founded in November 1999 and is headquartered in Dallas, TX.
PSTX - Poseida Therapeutics Inc - Stock Price Chart
TickerPSTX [NASD, RUT]
CompanyPoseida Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap382.99MEPS (ttm)-1.18
P/E-EPS this Y-5.06%
Forward P/E-EPS next Y-24.22%
PEG-EPS past 5Y-12.83%
P/S4.64EPS next 5Y2.70%
P/B4.52EPS Q/Q43.86%
Dividend-Sales Q/Q172.09%
Insider Own34.43%Inst Own49.84%
Insider Trans0.00%Inst Trans56.77%
Short Float8.20%EarningsMay 14/a
Analyst Recom1.00Target Price14.00
Avg Volume504.04K52W Range1.60 - 4.27
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
PGHL - Primega Group Holdings Ltd. - Stock Price Chart
TickerPGHL [NASD]
CompanyPrimega Group Holdings Ltd.
CountryHong Kong
IndustryEngineering & Construction
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-32.80%
Dividend-Sales Q/Q-2.40%
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.69M52W Range3.60 - 9.55
Primega Group Holdings Limited, through its subsidiaries, provides soil and rock transportation services in Hong Kong. The company offers various services, including diesel oil trading; and construction works comprising excavation and lateral support works, and bored piling. It primarily serves foundation and site formation subcontractors of property development and civil engineering projects. The company was incorporated in 2022 and is based in San Po Kong, Hong Kong.
OKLO - Oklo Inc. - Stock Price Chart
TickerOKLO [NYSE]
CompanyOklo Inc.
CountryUSA
IndustryUtilities - Regulated Electric
Market Cap1.12BEPS (ttm)0.19
P/E49.20EPS this Y43.35%
Forward P/E-EPS next Y-76.99%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.34EPS Q/Q-26.50%
Dividend-Sales Q/Q-
Insider Own43.20%Inst Own22.22%
Insider Trans0.00%Inst Trans0.29%
Short Float6.98%EarningsMay 29
Analyst Recom2.50Target Price11.75
Avg Volume4.21M52W Range7.05 - 18.80
Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.
LEXX - Lexaria Bioscience Corp - Stock Price Chart
TickerLEXX [NASD]
CompanyLexaria Bioscience Corp
CountryCanada
IndustryBiotechnology
Market Cap53.44MEPS (ttm)-1.13
P/E-EPS this Y56.44%
Forward P/E-EPS next Y10.61%
PEG-EPS past 5Y18.43%
P/S157.17EPS next 5Y-
P/B5.28EPS Q/Q41.04%
Dividend-Sales Q/Q139.90%
Insider Own10.38%Inst Own6.09%
Insider Trans0.00%Inst Trans7.38%
Short Float1.12%EarningsApr 09
Analyst Recom1.00Target Price10.00
Avg Volume219.48K52W Range0.76 - 6.85
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. Its products can be used with APIs fat-soluble vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) pain medications, hormones, phosphodiesterase inhibitors, antivirals, nicotine and its analogs, and all cannabinoids including tetrahydrocannabinol (THC) for therapeutic indications, as well as hypertension, SARS-CoV-2/COVID-19, and HIV/AIDS. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carle VanessaSecretaryMay 14 '24Option Exercise1.152,5002,8752,567May 15 05:37 PM
TOYO - TOYO Co Ltd. - Stock Price Chart
TickerTOYO [NASD]
CompanyTOYO Co Ltd.
CountryJapan
IndustryShell Companies
Market Cap129.54MEPS (ttm)0.18
P/E15.42EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.50EPS Q/Q-56.37%
Dividend-Sales Q/Q-
Insider Own9.60%Inst Own6.67%
Insider Trans0.00%Inst Trans0.16%
Short Float1.80%Earnings-
Analyst Recom-Target Price-
Avg Volume1.27M52W Range1.36 - 15.61
TOYO Co. Ltd. engages in the design, manufacture, and sale of solar cells and modules. It is involved in integrating the upstream production of wafer and silicon, midstream production of solar cell, downstream production of photovoltaic (PV) modules, and potentially other stages of the solar power supply chain. The company was founded on November 8, 2022 and is headquartered in Tokyo, Japan.
NNOX - Nano X Imaging Ltd - Stock Price Chart
TickerNNOX [NASD, RUT]
CompanyNano X Imaging Ltd
CountryIsrael
IndustryMedical Devices
Market Cap496.33MEPS (ttm)-1.08
P/E-EPS this Y19.20%
Forward P/E-EPS next Y38.64%
PEG-EPS past 5Y-91.56%
P/S49.58EPS next 5Y-
P/B2.68EPS Q/Q0.84%
Dividend-Sales Q/Q4.33%
Insider Own9.49%Inst Own16.80%
Insider Trans0.00%Inst Trans9.20%
Short Float12.65%EarningsMay 28/b
Analyst Recom1.00Target Price14.33
Avg Volume996.13K52W Range4.89 - 14.28
Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The firm operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Petach Tikva, Israel.
CARM - Carisma Therapeutics Inc - Stock Price Chart
TickerCARM [NASD]
CompanyCarisma Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap49.02MEPS (ttm)-2.01
P/E-EPS this Y52.05%
Forward P/E-EPS next Y16.91%
PEG-EPS past 5Y24.98%
P/S3.25EPS next 5Y-
P/B4.50EPS Q/Q75.95%
Dividend-Sales Q/Q4.75%
Insider Own51.45%Inst Own17.11%
Insider Trans0.00%Inst Trans-32.33%
Short Float5.12%EarningsMay 09/b
Analyst Recom1.40Target Price7.60
Avg Volume808.57K52W Range0.99 - 7.14
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
SXTC - China SXT Pharmaceuticals Inc - Stock Price Chart
TickerSXTC [NASD]
CompanyChina SXT Pharmaceuticals Inc
CountryChina
IndustryDrug Manufacturers - Specialty & Generic
Market Cap0.91MEPS (ttm)-1.16
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.53EPS next 5Y-
P/B4.44EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own4.80%Inst Own0.39%
Insider Trans0.00%Inst Trans297.32%
Short Float24.07%Earnings-
Analyst Recom-Target Price-
Avg Volume613.07K52W Range0.94 - 9.38
Oct-26-23 04:05PM China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule (GlobeNewswire) +6.75%
Oct-04-23 08:30AM China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split (GlobeNewswire)
Aug-02-23 06:03AM China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022) (Simply Wall St.)
May-10-23 08:00AM China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule (GlobeNewswire) +6.05%
Mar-29-23 09:43AM Insiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% drop (Simply Wall St.)
Nov-07-22 08:00AM China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency (GlobeNewswire)
May-18-22 12:30PM China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split (GlobeNewswire) -27.93%
Mar-14-22 10:33PM China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million (GlobeNewswire) -9.81%
Jan-20-22 12:30PM Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC). (ACCESSWIRE)
10:45AM China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment (GlobeNewswire)
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). Its product categories include directly-oral, after-soaking-oral, fine, and regular TCMP. The firm distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.
15678910111213141520